These results demonstrate that the increase in ketone bodies yielded by nutritional ketosis do not induce an increase in EPO secretion and they suggest a potential role of EPO on counteracting the metabolic stress associated to obesity and circulating levels of EPO could be a biomarker of the health status of patients under a weight-loss therapy. This evidence concerns the gene EPO and obesity due to melanocortin 4 receptor deficiency.